Results 221 to 230 of about 432,951 (336)

An Analysis of the mRNA Expression of Peripheral-Blood Stem and Progenitor Cell Markers in Pancreatic Neoplastic Disorders [PDF]

Krzysztof Dąbkowski, Maciej Tarnowski, Krzysztof Safranow, Maria Dąbkowska, Alicja Kosiorowska, Kamila Pukacka, Teresa Starzyñska   +6 more
openalex   +1 more source

A Tissue Renewal-Based Mechanism Drives Colon Tumorigenesis. [PDF]

Cancers (Basel)
Boman RM, Schleiniger G, Raymond C, Palazzo J, Shehab A, Boman BM.   +5 more
europepmc   +1 more source

Hypomethylating agents in vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic syndrome (VEXAS): A systematic review

British Journal of Haematology, EarlyView.
Summary VEXAS syndrome (vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic) is an X‐linked, systemic, haemato‐inflammatory syndrome caused by somatic mutations in the UBA1 gene. No standardized treatment guidelines exist, but evidence is emerging that treatment with hypomethylating agents (HMAs) can induce improvement of the inflammatory symptoms,
Fieke W. Hoff, Roochi Trikha, Emma M. Groarke, Bhavisha A. Patel   +3 more
wiley   +1 more source

Targeting MCL‐1 and MAPK overcomes venetoclax resistance in FLT3‐ITD‐positive AML cells harbouring activating PTPN11 (SHP‐2) mutations

British Journal of Haematology, EarlyView.
Summary Venetoclax (VEN)‐based therapies have improved the treatment of acute myeloid leukaemia (AML); however, the emergence of resistance remains a major limitation. Mutations in protein tyrosine phosphatase (PTP) non‐receptor type 11 (PTPN11) and FMS like tyrosine kinase 3 with internal tandem duplication (FLT3‐ITD) are common in resistant patients ...
Maximilian Fleischmann, Ole Hansen, Diana Voigtländer, Julia Bechwar, Lenny‐Joseph Schwietzer, Sanja Bahr, Ulf Schnetzke, Mike Fischer, Florian H. Heidel, Tina M. Schnöder, Jörg P. Müller, Andreas Hochhaus, Sebastian Scholl   +12 more
wiley   +1 more source

Engineering hypoimmune stem cell-derived beta cells. [PDF]

Stem Cell Res Ther
Licht BJM, Duffy GP, Levey RE.
europepmc   +1 more source

Immunodeficiency Diseases and Tumor Immunobiology [PDF]

, 1974
Abramoff, Peter A., Duquesnoy, Rene J.
core   +1 more source

3D <i>In Vitro</i> Models of the Bone Marrow Niche. [PDF]

ACS Biomater Sci Eng
Scala P, Serio B, Giudice V.
europepmc   +1 more source

Guideline of guidelines: management of small testicular masses

BJU International, EarlyView.
Objective To compare and summarise the most up to date international guidelines and major recommendations for the management of small testicular masses (STMs). Methods A systematic search was conducted in PubMed, EMBASE, Scopus, Google Scholar, and the Cochrane Library up to 1 November 2024.
Marco Tozzi, Giuseppe Fallara, Matteo Ferro, Francesco Chierigo, Roberto Bianchi, Hussain M. Alnajjar, Karl H. Pang, Asif Muneer   +7 more
wiley   +1 more source

Tumor necrosis factor promotes doublecortin-like kinase 1 expression and cellular reprogramming in intestinal epithelial cells leading to neoplastic transformation. [PDF]

Cell Commun Signal
Huang L, Li T, Huang X, Chen X, Ju Y, Xu L, Ma C, Tao Y, Yang Y, Bian X, Huycke MM, Wang X.   +11 more
europepmc   +1 more source

Unusual Cytology Features of A DICER1‐Mutated Thyroid Nodule: Raising Awareness of A Potential Diagnostic Pitfall During Fine Needle Aspiration

Cytopathology, EarlyView.
This article describes the unusual cytology features of a DICER1‐mutated thyroid nodule. Fine needle aspiration revealed predominantly cell debris/degenerated cells and rare viable follicular cells with mild cytologic atypia. Surgical resection revealed a nodule with nearly complete infarction, which is one specific feature of DICER1‐mutated thyroid ...
Wenli Dai, Eduardo V. Zambrano, Sabri Yilmaz, Qian Wang   +3 more
wiley   +1 more source